Swift Medical secures AI-related funding
By HME News Staff
Updated 9:32 AM CDT, Mon March 18, 2024
TORONTO – Swift Medical has announced a strategic co-investment from DIGITAL, Canada’s Global Innovation Cluster for digital technologies, to expedite the adoption and commercialization of the company’s AI technologies. The total project investment stands at $9 million, with DIGITAL co-investing $4.5 million, alongside project partners. “DIGITAL is excited to build upon the over five years of investments we’ve made in applied AI with this latest announcement,” said Nadia Shaikh-Naeem, vice president of programs at DIGITAL. “We continue to be proud to co-invest alongside innovators like Swift Medical, in collaboration with partners like Giishkaandago'Ikwe Health Services; Brightshores Health System; and the University of Northern British Columbia’s Centre for Technology Adoption for Aging in the North to deploy Swift Medical’s enhanced wound care solution within urban, rural and Indigenous communities. Partnerships such as these are how we can continue to build on Canada’s global reputation for AI R&D while focusing on advancing global commercial pathways for Canadian companies.” The partnership will focus on the deployment of Swift Medical's cutting-edge AI technologies in three tools: SmartTissue, AutoDepth and HealingIndex.
Comments